# K102211: Cruiser 18 Guidewire

- Pathway: 510(k) (Special)
- Applicant: Brivant, Ltd.
- Decided: Sep 3, 2010 after 29 days
- Product code: DQX (Wire, Guide, Catheter)
- Device class: 2
- Regulation: 21 CFR 870.1330
- Recalls of this device: none
- Data: FDA decisions to Oct 25, 2026; recalls to Oct 12, 2026

## Lineage
Longest line of descent: 6 generations back to K970376 (1997). 14 ancestors in all.
1 later device descends from it; 1 cites it directly.
0 of 16 devices in its family (counting itself) have a Class I recall.

## Predicates on the family tree (from the FDA summary)
- K060551: Brivant Guidewire, Brivant Limited (2006) Summary page 1.
- K073082: CPS Courier Guidewire, Brivant, Ltd. (2008) Summary page 1.

## Most influential descendants
- K120137: Victory Guidewire (32 Models) (2012), 0 descendants of its own

## Indications for use
The Cruiser-18 Guidewires are intended for use in the peripheral vasculature Contraindlications: The Cruiser-18 guide wire is not intended for use in the coronary or cerebral vasculature. Patients judged not acceptable for percutaneous intervention (PPCI)

Source page: https://510kreport.com/device/K102211
Methodology: https://510kreport.com/methodology